References
- Brumlik J, Yap C. Normal Tremor: A Comparative Study. Charles C Thomas, Springfield 1970; 4
- Parkinson J. An essay on the shaking palsy. Reprinted in. Med Classics 1937; 2: 964, 997
- Brumlik J, Yap C. Normal Tremor: A Comparative Study. Charles C Thomas, Springfield 1970; 5–13
- Wilson JW, Jr, Kunkle E C. Epinephrine tremor an experimental study. Trans Am Neurol Assn 1953; 78: 282, 284
- Graham J DP. Static tremor in anxiety states. J Neurol Neurosurg Psychiat 1945; 8: 57, 60
- Young R R. Pathophysiology and pharmacology of tremors. Electromyography in CNS Disorders, B T Shahani. Butterworth, Boston 1984; 143–159
- Jankovic J, Fahn S. Physiologic and pathologic tremors: diagnosis, mechanisms and management. Ann Intern Med 1980; 93: 460, 465
- Marsden C D., Foley T H., Owen D AL, McAllister R G. Peripheral beta-adrenergic receptors concerned with tremor. Clin Sci 1967; 33: 54, 65
- Larsson S, Svedmyr. Tremor caused by sympathomimetics is mediated by beta2-adrenoceptors. N Scand J Resp Dis 1977; 58: 5, 10
- Bowman W C., Zaimus E. The effects of adrenalin, noradrenaline, and isoprenaline on skeletal muscle contractions in the cat. JPhysiol 1958; 244: 92, 107
- Young R R., Hagbarth K E. Physiological tremor enhanced by manoeuvres affecting segmental stretch refles. J Neurol Neurosurg Phsychiatry 1980; 43: 248, 256
- Jenne J W., Ridley D J., Marcucci R A., Druz W S. Objective and subjective tremor responses to oral beta2 agents on first exposures. Am Rev Resp Dis 1982; 126: 607, 610
- Thiringer G, Svedmyr N. Evaluation of skeletal muscle tremor due to bronchodilating agents. Scand J Resp Dis 1975; 56: 93, 102
- Larsson S, Svedmyr N. Bronchodilating effect and side effects of beta2-adrenoreceptor stimulants by different modes of administration (tablet, metered-dose aerosol, and combination thereof). Am Rev Respir Dis 1977; 226: 861, 869
- Walker S R., Evans M E., Richads A J., Paterson J W. The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther 1972; 13: 861, 867
- Van Den, Berg W, Leferink J G., Maes R A., Fokkens J K., Kreukneit J, Bruynzeel P LB. The effects of oral and subcutaneous administration of terbutaline in asthmatic subjects. Eur J Resp Dis 1984; 234: 65H81–193, suppl
- Olson O AT, Swanberg E, Svedinger I, Waldeck B. Effects of B-adrenoceptor agonists on airway smooth muscle and on slow contracting skeletal muscles in vitro and in vivo. Acta Pharmacol Toxicol 1979; 44: 272, 276
- Lofdahl G, Svedmyr K, Svedmyr N, Andersson P, Bengtsson B, Olsson G AT, Waldeck B. Comparison of beta2-adrenoceptor stimulation in bronchial and skeletal muscle in experimental and clinical studies. Eur J Respir Dis 1984; 235: 124–127, (suppl)
- Lofdahl C G., Bengtsson B, Svedmyr K, Svedmyr N. Two new beta2 adrenoceptor agonists, D2342 and QH 25, studied in asthmatics. Allergy 1982; 37: 351, 357
- Jenne J W., Valcarenghi G, Druz W S., Yu C, Shaughnessy T K. Comparison of tremor responses to orally administered albuterol and terbutaline. Am Rev Resp Dis 1986; 234: 708, 713
- Billing B, Dahlqvist R, Garle M, Hornblad Y, Ripe E. Separate and combined use of terbutaline and theophylline, in asthmatics. Eur J Resp Dis 1982; 63: 399, 409
- Dyson A J., Campbell I A. Interaction between choline theophyllinate and salmefamol in patients with reversible airway obstruction. B J Clin Pharmacol 1977; 4: 677, 682
- Laursen L C., Taudorf E, Gnosspelius V, Gymose E, Weeke B. Long-term oral therapy of asthma with terbutaline and theophylline, alone and combined. Eur J Resp Dis 1985; 66: 82, 90
- Svedmyr N V., Larssen S A., Thiringer G K. Development “resistance” in beta-adrenergic receptors of asthmatic patients. Chest 1976; 69: 479, 483